Osteomark gets US clearance:
This article was originally published in Clinica
Ostex' bone resorption test, Osteomark, has received US FDA clearance and the Seattle-based company expects sales to begin in the summer. Already available in Europe, Canada and Australia, Osteomark is based on technology developed by Dr David Eyre of the University of Washington. Ostex says it plans to enter into at least one additional worldwide partnership for marketing the assay: it already has collaborative deals with Merck & Co, Boehringer Mannheim and Mochida Pharmaceutical.
You may also be interested in...
Unilever North America agrees SmartyPant, founded in 2011 to create a comprehensive supplement made from premium ingredients to support the wellbeing needs of children and adults. Kind, fully owned by Mars, has an agreement to acquire family-owned Nature's Bakery which offers snacks including fig bars and other soft-baked foods.
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.